These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12400200)

  • 1. Meaning and medication in the care of treatment-resistant patients.
    Mintz D
    Am J Psychother; 2002; 56(3):322-37. PubMed ID: 12400200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication noncompliance in adolescents with psychiatric disorders.
    Ghaziuddin N; King CA; Hovey JD; Zaccagnini J; Ghaziuddin M
    Child Psychiatry Hum Dev; 1999; 30(2):103-10. PubMed ID: 10668306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication: reasons and interventions for noncompliance.
    Forman L
    J Psychosoc Nurs Ment Health Serv; 1993 Oct; 31(10):23-5. PubMed ID: 8254571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication from an object relations theory perspective: an analysis of vignettes from group psychotherapy.
    Fain DS; Sharon A; Moscovici L; Schreiber S
    Int J Group Psychother; 2008 Jul; 58(3):303-26. PubMed ID: 18573024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A view from Riggs: treatment resistance and patient authority - III. What is psychodynamic psychopharmacology? An approach to pharmacologic treatment resistance.
    Mintz D; Belnap B
    J Am Acad Psychoanal Dyn Psychiatry; 2006; 34(4):581-601. PubMed ID: 17274730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconceptualizing medication adherence: six phases of dynamic adherence.
    Gearing RE; Townsend L; MacKenzie M; Charach A
    Harv Rev Psychiatry; 2011; 19(4):177-89. PubMed ID: 21790266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical sequelae of overt non-compliance with psychotropic agents.
    Littrell RA; Mainous AG; Karem F; Coyle WR; Reynolds CM
    Psychopharmacol Bull; 1994; 30(2):239-44. PubMed ID: 7831462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transference and countertransference to medication and its implications for ego function.
    Marcus ER
    J Am Acad Psychoanal Dyn Psychiatry; 2007; 35(2):211-8. PubMed ID: 17650974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery from Childhood Psychiatric Treatment: Addressing the Meaning of Medications.
    Mintz D
    Psychodyn Psychiatry; 2019; 47(3):235-256. PubMed ID: 31448987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social context, the struggle with uncertainty, and subjective risk as meaning-rich constructs for explaining HBP noncompliance.
    Proulx M; Leduc N; Vandelac L; Grégoire JP; Collin J
    Patient Educ Couns; 2007 Sep; 68(1):98-106. PubMed ID: 17596901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subjectivity and autonomy: meanings and narratives with respect to discontinuing psychiatric drugs].
    Parada TC
    Salud Colect; 2018; 14(3):513-529. PubMed ID: 30517560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward psychotropic medications.
    Fife SA; Ketzenberger KE; Olson JN
    Psychol Rep; 2012 Apr; 110(2):475-6. PubMed ID: 22662401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacists' attitudes toward and professional interactions with users of psychiatric medication.
    Phokeo V; Sproule B; Raman-Wilms L
    Psychiatr Serv; 2004 Dec; 55(12):1434-6. PubMed ID: 15572574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric psychotropic medication initiation and adherence: a literature review based on social exchange theory.
    Hamrin V; McCarthy EM; Tyson V
    J Child Adolesc Psychiatr Nurs; 2010 Aug; 23(3):151-72. PubMed ID: 20796098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacologic treatment in juvenile offenders.
    Soller MV; Karnik NS; Steiner H
    Child Adolesc Psychiatr Clin N Am; 2006 Apr; 15(2):477-99, x. PubMed ID: 16527667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of reasons of non-compliance to psychiatric treatment.
    Taj R; Khan S
    J Ayub Med Coll Abbottabad; 2005; 17(2):26-8. PubMed ID: 16092645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric patients' attitudes about medication and factors affecting noncompliance.
    Ruscher SM; de Wit R; Mazmanian D
    Psychiatr Serv; 1997 Jan; 48(1):82-5. PubMed ID: 9117506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey.
    Cooper C; Bebbington P; King M; Brugha T; Meltzer H; Bhugra D; Jenkins R
    Acta Psychiatr Scand; 2007 Jul; 116(1):47-53. PubMed ID: 17559600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial rights and psychotropic drugs: the case against administering involuntary medications to a defendant during trial.
    Klein DW
    Vanderbilt Law Rev; 2002; 55(1):165-218. PubMed ID: 12680366
    [No Abstract]   [Full Text] [Related]  

  • 20. Involuntary interventions: does the benefit exceed the cost?
    Schwartz CE
    Am J Psychiatry; 1992 Mar; 149(3):424-6. PubMed ID: 1637375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.